Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 1/2014

01-01-2014 | 80th Anniversary Special Issue

Functional Bowel Syndrome: Also a “Crohn” Disease?

Commentary on: Functional and Nervous Disorders of the Stomach and Alimentary Tract

Author: Eli D. Ehrenpreis

Published in: Digestive Diseases and Sciences | Issue 1/2014

Login to get access

Excerpt

Burrill R. Crohn (1884–1983), a pioneering gastroenterologist, is best known for a manuscript published in 1932 in the Journal of the American Medical Association, coauthored with Leon Ginzburg and Gordon Oppenheimer entitled “Terminal Ileitis: A New Clinical Entity” [2]. In this publication, he described 14 cases of a granulomatous inflammation of the distal ileum. Although descriptions of the condition had arguably been published previously, this landmark paper described clinical findings in the largest group of patients with inflammatory bowel disease at that time, and was the source of our current use of the author’s name for the disease. …
Literature
1.
Crohn BB. Functional and nervous disorders of the stomach and alimentary tract. Am J Dig Dis Nutr. 1934;1:773–777.CrossRef
2.
Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis—a pathologic and clinical entity. JAMA. 1932;99:1323–1329.CrossRef
3.
Everhart JE, ed. The burden of digestive diseases in the United States. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office; 2008. NIH publication no. 09-6443.
4.
5.
Spiller RC, Thompson WG. Rome foundation diagnostic algorithms: bowel disorders. Am J Gastroenterol. 2010;105:775–785.PubMedCrossRef
6.
Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995;122:107–112.PubMedCrossRef
Metadata
Title
Functional Bowel Syndrome: Also a “Crohn” Disease?
Commentary on: Functional and Nervous Disorders of the Stomach and Alimentary Tract
Author
Eli D. Ehrenpreis
Publication date
01-01-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2978-1

Other articles of this Issue 1/2014

Digestive Diseases and Sciences 1/2014 Go to the issue

Original Article

Ultrasound-Guided Endoscopic Biliary Drainage: A Useful Drainage Method for Biliary Decompression in Patients with Biliary Obstructions

Original Article

Surgeon’s Volume Is Not Associated with Complication Outcome After Laparoscopic Cholecystectomy

Original Article

Nitric Oxide Synthase Gene Polymorphisms in Functional Dyspepsia

Original Article

Impaired Sleep Quality in Crohn’s Disease Depends on Disease Activity

Original Article

Single Nucleotide Polymorphisms of Caudal Type Homeobox 1 and 2 Are Associated with Barrett’s Esophagus

Original Article

Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits